Every minute counts when waiting for accurate diagnostic test results to guide critical care decisions.
That's why today's clinical lab is more important than ever. About 13 billion diagnostic tests are performed in the U.S. each year, and nearly 70 percent of critical care decisions are driven by a diagnostic test.
As the world's older population continues to grow at an unprecedented rate, and with chronic diseases on the rise, the demands on labs are increasing significantly. So, how can labs operate more efficiently to better serve patients and positively shape the future of healthcare?
That's where Abbott's Alinity family of diagnostic systems comes in. The Alinity system is poised to change the industry's testing paradigm through efficiency, speed and scalability to help guide care for patients. Alinity is a family of harmonized products that provide screening ability for immunoassay, clinical chemistry, point of care, hematology, blood and plasma and molecular diagnostics.
Developed based on thousands of insights from clinicians, scientists, lab technicians, and healthcare executives, Alinity is designed to be intuitive, uniform across the lab, and to provide better ROI. This design allows lab technicians to perform high amounts of testing within a smaller footprint, and its scalable design is flexible to grow with the lab as their testing volumes increase over time rather than having to replace entire systems.
Additionally, Alinity makes it easier for lab technicians to perform their day-to-day jobs faster and with more accuracy as it is:
- Intuitive and easy-to-use, with an integrated, uniform interface across instruments making it quick to learn and easy to use for all lab personnel
- Continuously accessible and able to run any test at any time with the ability to replace reagents without stopping the instrument, improving lab productivity
- Error-proof, with proprietary lock-and-key reagent bottles so reagents can only fit in designated positions, helping safeguard against erroneous results
Delivering measurably better healthcare performance is the driving force behind Abbott's work to develop life-changing technology and diagnostic innovations such as Alinity. Alinity's journey begins in the U.S. with the launch of “Alinity c” clinical chemistry system and “Alinity i” immunoassay system, which can operate individually or as an integrated Alinity series.
Learn more about Alinity and how the new era of diagnostics testing is changing the healthcare paradigm at abbott.com/alinity.
